Great West Life Assurance Co. Can decreased its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 6.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 35,313 shares of the business services provider’s stock after selling 2,343 shares during the period. Great West Life Assurance Co. Can owned approximately 0.14% of Exponent worth $2,611,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. SG Americas Securities LLC bought a new position in shares of Exponent during the 2nd quarter valued at about $278,000. UBS Asset Management Americas Inc. boosted its position in shares of Exponent by 6.9% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 60,030 shares of the business services provider’s stock valued at $3,500,000 after purchasing an additional 3,857 shares in the last quarter. Nordea Investment Management AB boosted its position in shares of Exponent by 5.6% during the 3rd quarter. Nordea Investment Management AB now owns 32,461 shares of the business services provider’s stock valued at $2,399,000 after purchasing an additional 1,712 shares in the last quarter. Citadel Advisors LLC boosted its position in shares of Exponent by 70.1% during the 2nd quarter. Citadel Advisors LLC now owns 10,604 shares of the business services provider’s stock valued at $618,000 after purchasing an additional 4,370 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its position in shares of Exponent by 2.3% during the 2nd quarter. Principal Financial Group Inc. now owns 210,098 shares of the business services provider’s stock valued at $12,249,000 after purchasing an additional 4,794 shares in the last quarter. Institutional investors own 88.61% of the company’s stock.

Exponent, Inc. (EXPO) opened at $70.70 on Friday. Exponent, Inc. has a fifty-two week low of $55.75 and a fifty-two week high of $77.15. The company has a market cap of $1,855.79, a PE ratio of 39.29 and a beta of 0.57.

Exponent (NASDAQ:EXPO) last announced its earnings results on Wednesday, October 18th. The business services provider reported $0.54 EPS for the quarter, topping the consensus estimate of $0.45 by $0.09. Exponent had a net margin of 16.46% and a return on equity of 17.21%. The company had revenue of $87.60 million during the quarter, compared to analysts’ expectations of $79.69 million. During the same period last year, the company posted $0.42 earnings per share. The business’s revenue for the quarter was up 12.9% on a year-over-year basis. equities research analysts expect that Exponent, Inc. will post 2.09 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 22nd. Shareholders of record on Friday, December 1st will be issued a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 1.19%. The ex-dividend date of this dividend is Thursday, November 30th. Exponent’s payout ratio is 40.98%.

Several research analysts have commented on the stock. BidaskClub cut shares of Exponent from a “hold” rating to a “sell” rating in a report on Friday. Cantor Fitzgerald raised their target price on shares of Exponent to $82.00 and gave the stock an “overweight” rating in a report on Thursday, October 19th. Zacks Investment Research upgraded shares of Exponent from a “hold” rating to a “buy” rating and set a $81.00 target price for the company in a report on Friday, October 20th. Finally, SunTrust Banks reiterated a “hold” rating and issued a $77.00 target price on shares of Exponent in a report on Thursday, October 19th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $80.00.

In other news, CEO Paul R. Johnston sold 3,696 shares of the stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $70.86, for a total value of $261,898.56. Following the completion of the sale, the chief executive officer now directly owns 42,394 shares of the company’s stock, valued at $3,004,038.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Paul R. Johnston sold 4,000 shares of the stock in a transaction that occurred on Thursday, September 21st. The stock was sold at an average price of $72.42, for a total transaction of $289,680.00. Following the completion of the sale, the chief executive officer now directly owns 38,394 shares of the company’s stock, valued at $2,780,493.48. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,748 shares of company stock valued at $996,740. Corporate insiders own 2.80% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another publication, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/great-west-life-assurance-co-can-trims-stake-in-exponent-inc-expo/1764815.html.

About Exponent

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with Analyst Ratings Network's FREE daily email newsletter.